Company: | Affymax Inc, |
Ticker Symbol: | AFFY |
Class Period: | Dec-8-11 to Feb-22-13 |
Date Filed: | Feb-28-13 |
Lead Plaintiff Deadline: | Apr-29-13 |
Court: | Northern District of California |
Allegations: |
The lawsuit, which was filed in the United States District Court for the Northern District of California, alleges Affymax issued false and misleading statements to investors during the Class Period by failing to adequately disclose: (1) that the Company's FY 2012 financial guidance was materially overstated; (2) that reported sales of its primary drug product were not sustainable; and (3) that the defendants were materially overstating sales and understating the potential liabilities related to its primary drug product, including refunds and potential liability to injured patients.
If you acquired the securities of the defendants during the Class Period you may, no later than the Lead Plaintiff Deadline shown above, request that the Court appoint you as lead plaintiff through counsel of your choice. You may also choose to remain an absent class member. A lead plaintiff must meet certain requirements.